Status:
TERMINATED
Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy
Lead Sponsor:
Washington University School of Medicine
Conditions:
Pancreatic Cancer
Pancreas Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to prospectively determine the effects of administering proton pump inhibitors (PPIs) following pancreaticoduodenectomy on postoperative outcomes. The findings of this stu...
Eligibility Criteria
Inclusion
- All consecutive patients who will undergo pancreaticoduodenectomy with gastric/biliary reconstruction performed as definitive management for a benign or malignant disease at Washington University/Barnes-Jewish Hospital.
- At least 18 years of age.
- Ability to understand and willingness to sign an IRB approved written informed consent document.
Exclusion
- \<18 years of age
Key Trial Info
Start Date :
April 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 29 2024
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT05251233
Start Date
April 21 2022
End Date
June 29 2024
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110